Burden of skin diseases

References

• Bickers DR, Lim HW, Margolis D et al. The burden of skin diseases: 2004: a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J. Am. Acad. Dermatol.55, 490–500 (2006).
   PubMed Web of Science ®Google Scholar
• Johnson MT, Roberts J. Skin conditions and related need for medical care among persons 1–74 years. United States, 1971–1974. Vital Health Stat..212, i-v, 1–72 (1978).
   Google Scholar
• Wadsworth MEJ, Butterfield WJH. In: Without Prescription. OHF, London, UK 7, 13 (1968).
   Google Scholar
• Chren MM, Weinstock MA. Conceptual issues in measuring the burden of skin diseases. J. Invest. Dermatol. Symp. Proc.9, 97–100 (2004).
   PubMedGoogle Scholar
• Parkerson GR Jr, Broadhead WE, Tse CK. Quality of life and functional health of primary care patients. J. Clin. Epidemiol.45, 1303–1313 (1992).
   PubMed Web of Science ®Google Scholar
• Office of Population Census and Survey. General Household Survey 1978. HMSO, London, UK, 282 (1980).
   Google Scholar
• Office of Population Census and Survey. General Household Survey 1978. HMSO, London, UK, 104–112 (1991).
   Google Scholar
• Rea JN, Newhouse ML, Halil T. Skin disease in Lambeth. A community study of prevalence and use of medical care. Br. J. Prevent. Soc. Med.30, 107–114 (1976).
   PubMedGoogle Scholar
• Julian CG. Dermatology in general practice. Br. J. Dermatol.141, 518–520 (1999).
   PubMed Web of Science ®Google Scholar
• Fung WK, Lo KK. Prevalence of skin disease among school children and adolescents in a Student Health Service Center in Hong Kong. Pediatr. Dermatol.17, 440–446 (2000).
   PubMed Web of Science ®Google Scholar
• World Health Organisation. Constitution of the World Health Organisation. Handbook of Basic Documents. 5th Edition. Palis des Nations, Geneva, Switzerland, 3–20 (1952).
   Google Scholar
• World Health Organisation. International Classification of Impairments, Disabilities and Handicaps. World Health Organisation, Geneva, Switzerland, 27–29 (1980).
   Google Scholar
• Doward LC, McKenna SP. Defining patient-reported outcomes. Value in Health7(Suppl. 1), S4–S8 (2004).
   PubMed Web of Science ®Google Scholar
• Gray DB, Hendershot GE. The ICIDH-2: developments for a new era of outcomes research. Arch. Phys. Med. Rehabil.81(Suppl. 2), S10–S14 (2000).
   PubMed Web of Science ®Google Scholar
• World Health Organisation. ICIDH-2; International Classification of Functioning and Disability. Beta-2 draft, full version. World Health Organisation, Geneva, Switzerland (1999).
   Google Scholar
• Haas BK. Clarification and integration of similar quality of life concepts. J. Nurs. Scholar.31, 215–220 (1999).
   Google Scholar
• Sullivan M. Quality of life in medicine. Nordic J. Psychiatr.46, 79–83 (1992).
   Google Scholar
• Halioua B, Beumont MG, Lunel F. Quality of life in dermatology. Int. J. Dermatol.39, 801–806 (2000).
   PubMed Web of Science ®Google Scholar
• Finlay AY. Quality of life measurement in dermatology: a practical guide. Br. J. Dermatol.136, 305–314 (1997).
   PubMed Web of Science ®Google Scholar
• Finlay AY. Quality of life assessments in dermatology. Semin. Cutan. Med. Surg.17, 291–296 (1998).
   PubMed Web of Science ®Google Scholar
• Fitzpatrick R, Fletcher A, Gore S et al. Quality of life measures in health care. I: Applications and issues in assessment. BMJ305, 1074–1077 (1992).
   PubMed Web of Science ®Google Scholar
• Gupta MA, Johnson AM, Chren MM. Evaluating clinical rating scales for evidence-based dermatology: some basic concepts. Dermatol. Clin.23, 703–706 (2005).
   PubMed Web of Science ®Google Scholar
• Chren MM, Lasek RJ, Quinn LM, Covinsky KE. Convergent and discriminant validity of a generic and a disease-specific instrument to measure quality of life in patients with skin disease. J. Invest. Dermatol.108, 103–107 (1997).
   PubMed Web of Science ®Google Scholar
• Mallon E, Newton JN, Klassen AF et al. Standard patient-assessed quality of life instruments can be used to measure the benefits of acne treatment. Br. J. Dermatol.133, 35 (1995).
   Google Scholar
• Rapp SR, Feldman SR, Exum ML et al. Psoriasis causes as much disability as other major medical diseases. J. Am. Acad. Dermatol.41, 401–407 (1999).
   PubMed Web of Science ®Google Scholar
• Klassen AF, Newton JN, Mallon E. Measuring quality of life in people referred for specialist care of acne: comparing generic and disease-specific measures. J. Am. Acad. Dermatol.43, 229–233 (2000).
   PubMed Web of Science ®Google Scholar
• van de Kerkhof PC. The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial. Br. J. Dermatol.151, 663–668 (2004).
   PubMed Web of Science ®Google Scholar
• Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) – a simple practical measure for routine clinical use. Clin. Exp. Dermatol.19, 210–216 (1994).
   PubMed Web of Science ®Google Scholar
• Chren MM, Lasek RJ, Quinn LM et al. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J. Invest. Dermatol.107, 707–713 (1996).
   PubMed Web of Science ®Google Scholar
• Morgan M, McCreedy R, Simpson J, Hay RJ. Dermatology Quality of Life Scales – a measure of the impact of skin diseases. Br. J. Dermatol.136, 20220–20226 (1997).
   Google Scholar
• Basra MKA, Fenech R, Gatt RM et al. The Dermatology Life Quality Index 1994–2007: a comprehensive review of validation data and clinical results. Br. J. Dermatol.159, 997–1035 (2008).
   PubMed Web of Science ®Google Scholar
• Finlay AY, Kelly SE. Psoriasis – an index of disability. Clin. Exp. Dermatol.12, 8–11 (1987).
   PubMed Web of Science ®Google Scholar
• Motley RJ, Finlay AY. Practical use of Acne Disability Index in the routine management of acne. Clin. Exp. Dermatol.17, 1–3 (1992).
   PubMed Web of Science ®Google Scholar
• Whalley D, McKenna SP, Dewar AL et al. A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD). Br. J. Dermatol.150, 274–283 (2004).
   PubMed Web of Science ®Google Scholar
• O’Donnell BF, Lawlor F, Simpson J. Chronic urticaria: impact on quality of life. Br. J. Dermatol.133, 197–201 (1995).
   Google Scholar
• Zug KA, Littenberg B, Baughman RD et al. Assessing the preferences of patients with psoriasis: a quantitative, utility approach. Arch. Dermatol.131, 561–568 (1995).
   PubMedGoogle Scholar
• Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br. J. Dermatol.132, 236–244 (1995).
   PubMed Web of Science ®Google Scholar
• Simpson NB. Social and economic aspects of acne and the cost–effectiveness of isotretinoin. J. Dermatol. Treat.4, S6–S9 (1993).
   Google Scholar
• Motley RJ, Finlay AY. How much disability is caused by acne? Clin. Exp. Dermatol.14, 194–198 (1989).
   PubMed Web of Science ®Google Scholar
• Schiffner R, Schiffner-Rohe J, Gerstenhauer M et al. Willingness to pay and time trade-off: sensitive to changes of quality of life in psoriasis patients? Br. J. Dermatol.148, 1153–1160 (2003).
   PubMed Web of Science ®Google Scholar
• Finlay AY. Measures of the effect of adult severe atopic eczema on quality of life. J. Eur. Acad. Dermatol. Venereol.7, 149–154 (1996).
   Google Scholar
• Basra MK, Finlay AY. The family impact of skin diseases: the greater patient concept. Br. J. Dermatol.156, 929–937 (2007).
   PubMed Web of Science ®Google Scholar
• Basra MK, Sue-Ho R, Finlay AY. The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease. Br. J. Dermatol.156, 528–538 (2007).
   PubMed Web of Science ®Google Scholar
• McKenna SP, Whalley D, Dewar AL et al. International development of the Parents’ Index Quality of Life in Atopic Dermatitis (PIQoL-AD). Qual. Life Res.14, 231–241 (2005).
   PubMed Web of Science ®Google Scholar
• Beasley R, von Keil U, Mutius E, Pearce N. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet351, 1225–1232 (1998).
   PubMed Web of Science ®Google Scholar
• Su JC, Kemp AS, Varigos GA, Nolan TM. Atopic eczema: its impact on the family and financial cost. Arch. Dis. Child.76, 159–162 (1997).
   PubMed Web of Science ®Google Scholar
• Butland BK, Strachan DP, Lewis S et al. Investigation into the increase in hay fever and eczema at age 16 observed between the 1958 and 1970 British birth cohorts. BMJ315, 717–721 (1997).
   PubMedGoogle Scholar
• Bjorksten B, Dumitrascu D, Foucard T et al. Prevalence of childhood asthma, rhinitis and eczema in Scandinavia and Eastern Europe. Eur. Respir. J.12, 432–437 (1998).
   PubMed Web of Science ®Google Scholar
• Kiebert G, Sorensen SV, Revicki D et al. Atopic dermatitis is associated with a decrement in health-related quality of life. Int. J. Dermatol.41, 151–158 (2002).
   PubMed Web of Science ®Google Scholar
• Anderson RT, Rajagopalan R. Effects of allergic dermatosis on health-related quality of life. Curr. Allergy Asthma Rep.1, 309–315 (2001).
   PubMedGoogle Scholar
• Solomon CR, Gagnon C. Mother and child characteristics and involvement in dyads in which very young children have eczema. J. Dev. Behav. Pediatr.8, 213–220 (1987).
   PubMed Web of Science ®Google Scholar
• Lawson V, Lewis-Jones MS, Finlay AY et al. The family impact of childhood atopic dermatitis: the Dermatitis Family Impact Questionnaire. Br. J. Dermatol.138, 107–113 (1998).
   PubMed Web of Science ®Google Scholar
• Yosipovitch G, Goon AT, Wee J et al. Itch characteristics in Chinese patients with atopic dermatitis using a new questionnaire for the assessment of pruritus. Int. J. Dermatol.41, 212–216 (2002).
   PubMed Web of Science ®Google Scholar
• Reid P, Lewis-Jones MS. Sleep difficulties and their management in preschoolers with atopic eczema. Clin. Exp. Dermatol.20, 38–41 (1995).
   PubMed Web of Science ®Google Scholar
• Verboom P, Hakkaart-Van L, Sturkenboom M et al. The cost of atopic dermatitis in the Netherlands: an international comparison. Br. J. Dermatol.147, 716–724 (2002).
   PubMed Web of Science ®Google Scholar
• Lapidus CS, Schwarz DF, Honig PJ. Atopic dermatitis in children: who cares? Who pays? J. Am. Acad. Dermatol.28, 699–703 (1993).
   PubMed Web of Science ®Google Scholar
• Ellis CN, Drake LA, Prendergast MM et al. Cost of atopic dermatitis and eczema in the United States. J. Am. Acad. Dermatol.46, 361–370 (2002).
   PubMed Web of Science ®Google Scholar
• Finlay AY, Ortonne JP. Patient satisfaction with psoriasis therapies: an update and introduction to biologic therapy. J. Cutan. Med. Surg.8, 310–320 (2004).
   PubMed Web of Science ®Google Scholar
• Seville RH. Psoriasis and stress. Br. J. Dermatol.97, 297–302 (1977).
   PubMed Web of Science ®Google Scholar
• Ginsburg IH, Link BG. Feelings of stigmatization in patients with psoriasis. J. Am. Acad. Dermatol.20, 53–63 (1989).
   PubMed Web of Science ®Google Scholar
• Gupta MA, Gupta AK, Kirkby S et al. A psychocutaneous profile of psoriasis patients who are stress reactors. A study of 127 patients. Gen. Hosp. Psychiatr.11, 166–173 (1989).
   PubMed Web of Science ®Google Scholar
• Gupta MA, Schork NJ, Gupta AK et al. Suicidal ideation in psoriasis. Int. J. Dermatol.32, 188–190 (1993).
   PubMed Web of Science ®Google Scholar
• Schmid-Ott G, Jaeger B, Kuensebeck HW et al. Dimensions of stigmatization in patients with psoriasis in a “Questionnaire on Experience with Skin Complaints”. Dermatology193, 304–310 (1996).
   PubMed Web of Science ®Google Scholar
• Fried RG, Friedman S, Paradis C et al. Trivial or terrible? The psychosocial impact of psoriasis. Int. J. Dermatol.34, 101–105 (1995).
   PubMed Web of Science ®Google Scholar
• Ramsay B, O’Reagan M. A survey of the social and psychological effects of psoriasis. Br. J. Dermatol.118, 195–201 (1988).
   PubMed Web of Science ®Google Scholar
• Gottlieb AB, Chao C, Dann F. Psoriasis comorbidities. J. Dermatolog. Treat.19, 5–21 (2008).
   PubMed Web of Science ®Google Scholar
• Christophers E. Comorbidities in psoriasis. Clin. Dermatol.25, 529–534 (2007).
   PubMed Web of Science ®Google Scholar
• Wu Y, Mills D, Bala M. Psoriasis: cardiovascular risk factors and other disease comorbidities. J. Drugs Dermatol.7, 373–377 (2008).
   PubMed Web of Science ®Google Scholar
• Gisondi P, Tessari G, Conti A et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case–control study. Br. J. Dermatol.157, 68–73 (2007).
   PubMed Web of Science ®Google Scholar
• Eghlileb AM, Davies EE, Finlay AY. Psoriasis has a major secondary impact on the lives of family members and partners. Br. J. Dermatol.156, 1245–1250 (2007).
   PubMed Web of Science ®Google Scholar
• Poikolainen K, Reunala T, Karvonen J et al. Alcohol intake: a risk factor for psoriasis in young and middle aged men? BMJ300, 780–783 (1990).
   PubMed Web of Science ®Google Scholar
• Gupta MA, Schork NJ, Gupta AK, Ellis CN. Alcohol intake and treatment responsiveness of psoriasis: a prospective study. J. Am. Acad. Dermatol.28, 730–732 (1993).
   PubMed Web of Science ®Google Scholar
• Mills CM, Srivastava ED, Harvey IM et al. Smoking habits in psoriasis: a case–control study. Br. J. Dermatol.127, 18–21 (1992).
   PubMed Web of Science ®Google Scholar
• Gupta MA, Gupta AK, Watteel GN. Cigarette smoking in men may be a risk factor for increased severity of psoriasis of the extremities. Br. J. Dermatol.135, 859–860 (1996).
   PubMed Web of Science ®Google Scholar
• Krueger G, Koo J, Lebwohl M et al. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch. Dermatol.137, 280–284 (2001).
   PubMed Web of Science ®Google Scholar
• Finzi AF, Mantovani LG, Belisari A. The cost of hospital-related care of patients with psoriasis in Italy based on the AISP study. Associazione Italiana Studi Psoriasis. J. Eur. Acad. Dermatol. Venereol.15, 320–324 (2001).
   PubMed Web of Science ®Google Scholar
• Feldman SR, Fleischer AB Jr, Reboussin DM et al. The economic impact of psoriasis increases with psoriasis severity. J. Am. Acad. Dermatol.37, 564–569 (1997).
   PubMed Web of Science ®Google Scholar
• Leyden JJ, Shalita AR. Rational therapy for acne vulgaris: an update on topical treatment. J. Am. Acad. Dermatol.15, 907–915 (1986).
   PubMed Web of Science ®Google Scholar
• White GM. Recent findings in the epidemiologic evidence, classification, and sub-types of acne vulgaris. J. Am. Acad. Dermatol.39, S34–S37 (1998).
   PubMed Web of Science ®Google Scholar
• Goulden V, Clark SM, Cunliffe WJ. Post-adolescent acne: a review of clinical features. Br. J. Dermatol.136, 66–70 (1997).
   PubMed Web of Science ®Google Scholar
• Mallon E, Newton JN, Klassen A et al. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br. J. Dermatol.140, 672–676 (1999).
   PubMed Web of Science ®Google Scholar
• Layton AM. Optimal management of acne to prevent scarring and psychological sequelae. Am. J. Clin. Dermatol.2, 135–141 (2001).
   PubMedGoogle Scholar
• Gupta MA, Gupta AK. The psychological comorbidity in acne. Clin. Dermatol.19, 360–363 (2001).
   PubMed Web of Science ®Google Scholar
• Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br. J. Dermatol.139, 846–850 (1998).
   PubMed Web of Science ®Google Scholar
• Wu SF, Kinder BN, Trunnell TN, Fulton JE. Role of anxiety and anger in acne patients: a relationship with the severity of the disorder. J. Am. Acad. Dermatol.18, 325–333 (1988).
   PubMed Web of Science ®Google Scholar
• Schachter RJ, Pantel ES, Glassman GM, Zweibelson I. Acne vulgaris and psychologic impact on high school students. NY State J. Med.71, 2886–2890 (1971).
   PubMedGoogle Scholar
• Jowett S, Ryan T. Skin disease and handicap: an analysis of the impact of skin conditions. Soc. Sci. Med.20, 42542–42549 (1985).
   Google Scholar
• Cunliffe WJ. Acne and unemployment. Br. J. Dermatol.115, 386 (1986).
   PubMed Web of Science ®Google Scholar
• Bergfeld WF. The evaluation and management of acne: economic considerations. J. Am. Acad. Dermatol.32, S52–S56 (1995).
   Google Scholar
• Stern RS. Acne therapy. Medication use and sources of care in office-based practice. Arch. Dermatol.132, 776–780 (1996).
   PubMed Web of Science ®Google Scholar
• Strasburger VC. Acne. What every pediatrician should know about treatment. Pediatr. Clin. North Am.44, 1505–1523 (1997).
   PubMed Web of Science ®Google Scholar
• Callender VD. Acne in ethnic skin: special considerations for therapy. Dermatolog. Ther.17, 184–195 (2004).
   PubMedGoogle Scholar
• Nordlund JJ. The epidemiology and genetics of vitiligo. Clin. Dermatol.15, 875–878 (1997).
   PubMed Web of Science ®Google Scholar
• Kent G, al-Abadie M. Factors affecting responses on the Dermatology Life Quality Index items among vitiligo sufferers. Clin. Exp. Dermatol.21, 330–333 (1996).
   PubMed Web of Science ®Google Scholar
• Salzer BA, Schallreuter KU. Investigation of the personality structure in patients with vitiligo and a possible association with impaired catecholamine metabolism. Dermatology190, 109–115 (1995).
   PubMed Web of Science ®Google Scholar
• van Moffaert M. Psychodermatology: an overview. Psychother. Psychosom.58, 125–136 (1992).
   PubMed Web of Science ®Google Scholar
• Porter J, Beuf AH, Nordlund JJ, Lerner AB. Psychological reaction to chronic skin disorders: a study of patients with vitiligo. Gen. Hosp. Psychiatr.y 1, 73–77 (1979).
   PubMed Web of Science ®Google Scholar
• Porter JR, Beuf AH, Lerner A, Nordlund J. Psychosocial effect of vitiligo: a comparison of vitiligo patients with “normal” control subjects, with psoriasis patients, and with patients with other pigmentary disorders. J. Am. Acad. Dermatol.15, 220–224 (1986).
   PubMed Web of Science ®Google Scholar
• Ongenae K, Van Geel N, De Schepper S, Naeyaert JM. Effect of vitiligo on self-reported health-related quality of life. Br. J. Dermatol.152, 1165–1172 (2005).
   PubMed Web of Science ®Google Scholar
• Porter JR, Beuf AH, Lerner AB, Nordlund JJ. The effect of vitiligo on sexual relationships. J. Am. Acad. Dermatol.22, 221–222 (1990).
   PubMed Web of Science ®Google Scholar
• Frist TF. Stigma and societal response to leprosy: experience of the last half century. Indian J. Lepr.72, 1–3 (2000).
   PubMedGoogle Scholar
• Chatterjee RN, Nandi DN, Banerjee G et al. The social and psychological correlates of leprosy. Indian J. Psychiatr.31, 315–318 (1989).
   PubMedGoogle Scholar
• Srinivasan H. Disability and rehabilitation in leprosy: issues and challenges. Indian J. Lepr.72, 317–337 (2000).
   PubMedGoogle Scholar
• Bharath S, Shamasundar C, Raghuram R, Subbakrishna DK. Correlates of psychiatric morbidity in patients with leprosy. Indian J. Lepr.73, 217–228 (2001).
   PubMedGoogle Scholar
• Verma KK, Gautam S. Psychiatric morbidity in displaced leprosy patients. Indian J. Lepr.66, 339–343 (1994).
   PubMedGoogle Scholar
• Behere PB. Psychological reactions to leprosy. Lepr. India53, 266–272 (1981).
   PubMedGoogle Scholar
• Raju MS, Kopparty SN. Impact of knowledge of leprosy on the attitude towards leprosy patients: a community study. Indian J. Lepr.67, 259–272 (1995).
   PubMedGoogle Scholar
• Kopparty SN, Kurup AM, Sivaram M. Problems and coping strategies of families having patients with and without deformities. Indian J. Lepr.67, 133–152 (1995).
   PubMedGoogle Scholar
• Kumar A, Anbalagan M. Socio–economic experiences of leprosy patients. Lepr. India55, 314–321 (1983).
   PubMedGoogle Scholar
• Kaur H, Ramesh V. Social problems of women leprosy patients – a study conducted at 2 urban leprosy centres in Delhi. Lepr. Rev.65, 361–375 (1994).
   PubMed Web of Science ®Google Scholar
• Cornwall JV, Dore CJ, Lewis JD. Leg ulcers: epidemiology and aetiology. Br. J. Surg.73, 693–696 (1986).
   PubMed Web of Science ®Google Scholar
• Nelzen O, Bergqvist D, Lindhagen A, Hallbook T. Chronic leg ulcers: an underestimated problem in primary health care among elderly patients. J. Epidemiol. Community Health45, 184–187 (1991).
   PubMed Web of Science ®Google Scholar
• Harrison MB, Graham ID, Friedberg E et al. Regional planning study: assessing the population with leg and foot ulcers. Can. Nurse97, 18–23 (2001).
   PubMedGoogle Scholar
• Baker SR, Stacey MC. Epidemiology of chronic leg ulcers in Australia. ANJ J. Surg.64, 258–261 (2008).
   Web of Science ®Google Scholar
• Callam MJ, Harper DR, Dale JJ, Ruckley CV. Chronic leg ulceration: socio–economic aspects. Scott. Med. J.33, 358–360 (1988).
   PubMed Web of Science ®Google Scholar
• Kenkre JE, Hobbs FD, Carter YH et al. A randomized controlled trial of electromagnetic therapy in the primary care management of venous leg ulceration. Fam. Pract.13, 236–241 (1996).
   PubMed Web of Science ®Google Scholar
• Phillips T, Stanton B, Provan A, Lew R. A study of the impact of leg ulcers on quality of life: financial, social, and psychologic implications. J. Am. Acad. Dermatol.31, 49–53 (1994).
   PubMed Web of Science ®Google Scholar
• Simon DA, Freak L, Kinsella A et al. Community leg ulcer clinics: a comprehensive study in two health authorities. BMJ312, 1648–1651 (1996).
   PubMedGoogle Scholar
• Ruckley CV. Socioeconomic impact of chronic venous insufficiency and leg ulcers. Angiology48, 67–69 (1997).
   PubMed Web of Science ®Google Scholar
• Moffatt CJ, Franks PJ, Oldroyd M et al. Community clinics for leg ulcers and impact on healing. BMJ305, 1389–1392 (1992).
   PubMedGoogle Scholar
• Lees TA, Lambert D. Prevalence of lower limb ulceration in an urban health district. Br. J. Surg.79, 1032–1034 (1992).
   PubMed Web of Science ®Google Scholar
• Tennvall GR, Hjelmgren J. Annual costs of treatment for venous leg ulcers in Sweden and the United Kingdom. Wound Repair Regen.13, 13–18 (2005).
   PubMed Web of Science ®Google Scholar
• Kerstein MD, Gemmen E, van Rijswijk L et al. Cost and cost–effectiveness of venous and pressure ulcer protocols of care. Dis. Manag. Health Outcomes9, 636–651 (2001).
   Google Scholar
• Lens MB, Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br. J. Dermatol.150, 179–185 (2004).
   PubMed Web of Science ®Google Scholar
• Surveillance Research Program, Cancer Statistics Branch, Surveillance, Epidemiology and End Results (SEER) Program. Washington DC: National Cancer Institute (2005).
   Google Scholar
• Ferlay J, Bray F, Pisani P, Perkin DM. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No 5, version 2.0. IARC Press, Lyon, France (2004).
   Google Scholar
• de Vries E, Coebergh JW. Cutaneous malignant melanoma in Europe. Eur. J. Cancer40, 2355–2366 (2004).
   PubMed Web of Science ®Google Scholar
• Brochez L, Myny K, Bleyen L et al. The melanoma burden in Belgium; premature morbidity and mortality make melanoma a considerable health problem. Melanoma Res.9, 614–618 (1999).
   PubMed Web of Science ®Google Scholar
• Osterlind A. Epidemiology on malignant melanoma in Europe. Acta Oncol.31, 903–908 (1992).
   PubMed Web of Science ®Google Scholar
• Albert VA, Koh HK, Geller AC et al. Years of potential life lost: another indicator of the impact of cutaneous malignant melanoma on society. J. Am. Acad. Dermatol.23(2 Pt 1), 308–310 (1990).
   PubMed Web of Science ®Google Scholar
• Barth A, Wanek LA, Morton DL. Prognostic factors in 1,521 melanoma patients with distant metastases. J. Am. Coll. Surg.181, 193–201 (1995).
   PubMed Web of Science ®Google Scholar
• Eton O, Legha SS, Moon TE et al. Prognostic factors for survival of patients treated systemically for disseminated melanoma. J. Clin. Oncol.16, 1103–1111 (1998).
   PubMed Web of Science ®Google Scholar
• Fawzy FI, Cousins N, Fawzy NW et al. A structured psychiatric intervention for cancer patients. I. Changes over time in methods of coping and affective disturbance. Arch. Gen. Psychiatr.47, 720–725 (1990).
   PubMed Web of Science ®Google Scholar
• Brandberg Y, Bolund C, Sigurdardottir V et al. Anxiety and depressive symptoms at different stages of malignant melanoma. Psychooncology2, 71–78 (1992).
   Google Scholar
• Brandberg Y, Bergenmar M, Bolund C et al. Psychological effects of participation in a prevention programme for individuals with increased risk for malignant melanoma. Eur. J. Cancer28, 1334–1338 (1992).
   Web of Science ®Google Scholar
• Joseph AK, Mark TL, Mueller C. The period prevalence and costs of treating nonmelanoma skin cancers in patients over 65 years of age covered by medicare. Dermatol. Surg.27, 955–959 (2001).
   PubMed Web of Science ®Google Scholar
• Diepgen TL, Mahler V. The epidemiology of skin cancer. Br. J. Dermatol.146(Suppl. 61), 1–6 (2002).
   PubMed Web of Science ®Google Scholar
• Green A. Changing patterns in incidence of nonmelanoma skin cancer. Epithelial Cell Biol.1, 47–51 (1992).
   PubMedGoogle Scholar
• Glass AG, Hoover RN. The emerging epidemic of melanoma and squamous cell skin cancer. JAMA262, 2097–2100 (1989).
   PubMed Web of Science ®Google Scholar
• Cheng SY, Luk NM, Chong LY. Special features of non-melanoma skin cancer in Hong Kong Chinese patients: 10-year retrospective study. HKMJ7, 22–28 (2001).
   Google Scholar
• Anne WL, Pfender E, Pillay E et al. Psychosocial aspects of epidermolysis bullosa: Proceedings of the 2nd International Symposium on Epidermolysis Bullosa, Santiago, Chile. Int. J. Dermatol.46, 809–814 (2007).
   PubMed Web of Science ®Google Scholar
• Fine JD, Johnson LB, Weiner M et al. Impact of inherited epidermolysis bullosa on parental interpersonal relationships, marital status and family size. Br. J. Dermatol.152, 1009–1014 (2004).
   Web of Science ®Google Scholar
• O’Donnell BF, Lawlor F, Simpson J et al. The impact of chronic urticaria on the quality of life. Br. J. Dermatol.136, 197–201 (1997).
   PubMed Web of Science ®Google Scholar
• Andre J, Achten G. Onychomycosis. Int. J. Dermatol.26, 481–490 (1987).
   PubMed Web of Science ®Google Scholar
• Walshe MM, English MP. Fungi in nails. Br. J. Dermatol.78, 198–207 (1966).
   PubMed Web of Science ®Google Scholar
• Scher RK. Onychomycosis is more than a cosmetic problem. Br. J. Dermatol.130(S43), 15 (1994).
   PubMed Web of Science ®Google Scholar
• Drake LA, Scher RK, Smith EB et al. Effect of onychomycosis on quality of life. J. Am. Acad. Dermatol.38, 702–704 (1998).
   PubMed Web of Science ®Google Scholar
• Lubeck DP, Patrick DL, McNulty P et al. Quality of life of persons with onychomycosis. Qual. Life Res.2, 341–348 (1993).
   PubMed Web of Science ®Google Scholar
• Einarson TR, Arikian SR, Shear NH. Cost–effectiveness analysis for onychomycosis therapy in Canada from a government perspective. Br. J. Dermatol.130(Suppl. 43), 32–34 (1994).
   PubMed Web of Science ®Google Scholar
• Freedman TG. Social and cultural dimensions of hair loss in women treated for breast cancer. Cancer Nurs.17, 334–341 (1994).
   PubMed Web of Science ®Google Scholar
• Hamilton JB. Patterned loss of hair in man; types and incidence. Ann. NY Acad. Sci.53, 708–728 (1951).
   PubMed Web of Science ®Google Scholar
• Maffei C, Fossati A, Rinaldi F, Riva E. Personality disorders and psychopathologic symptoms in patients with androgenetic alopecia. Arch. Dermatol.130, 8688–8672 (1994).
   Google Scholar
• Wells PA, Willmoth T, Russell RJ. Does fortune favour the bald? Psychological correlates of hair loss in males. Br. J. Psychol.86, 337–344 (1995).
   PubMed Web of Science ®Google Scholar
• van Der Donk J, Hunfeld JA, Passchier J et al. Quality of life and maladjustment associated with hair loss in women with alopecia androgenetica. Soc. Sci. Med.38, 159–163 (1994).
   PubMed Web of Science ®Google Scholar
• Cash TF, Price VH, Savin RC. Psychological effects of androgenetic alopecia on women: comparisons with balding men and with female control subjects. J. Am. Acad. Dermatol.29, 568–575 (1993).
   PubMed Web of Science ®Google Scholar
• Koo JY, Shellow WV, Hallman CP, Edwards JE. Alopecia areata and increased prevalence of psychiatric disorders. Int. J. Dermatol.33, 849–850 (1994).
   PubMedGoogle Scholar
• VanderPlate C, Aral SO. Psychosocial aspects of genital herpes virus infection. Health Psychol.6, 57–72 (1987).
   PubMed Web of Science ®Google Scholar
• Smith H, Pomerantz E. Getting back to normal: one woman’s experience with vulvodynia. J. Obstet. Gynecol.20, 10–13 (1996).
   Google Scholar
• Adams PF, Hendershot GE, Marano MA. Current estimates from the National Health Interview Survey, 1996. Vital Health Stat.10, 1–203 (1999).
   Google Scholar
• Johnson ML, Johnson KG, Engel A. Prevalence, morbidity, and cost of dermatologic diseases. J. Am. Acad. Dermatol.11, 930–936 (1984).
   PubMed Web of Science ®Google Scholar
• Beattie PE, Lewis-Jones MS. A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases. Br. J. Dermatol.155, 145–151 (2006).
   PubMed Web of Science ®Google Scholar
• Torrance GW. Utility approach to measuring health-related quality of life. J. Chronic Dis.40, 593–603 (1987).
   PubMedGoogle Scholar